Albright's Hereditary OsteodystrophySymptoms, Doctors, Treatments, Advances & More
Albright's Hereditary Osteodystrophy Overview
Learn About Albright's Hereditary Osteodystrophy
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Office
Michael Levine is an Endocrinologist practicing medicine in Philadelphia, Pennsylvania. Dr. Levine is rated as an Elite provider by MediFind in the treatment of Albright's Hereditary Osteodystrophy. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Hypercalcemia, Milk-Alkali Syndrome, Hypoparathyroidism, Hormone Replacement Therapy (HRT), and Parathyroidectomy.
Connecticut Children's Specialty Care Center-Farmington
Emily Germain is a Pediatric Endocrinologist practicing medicine in Farmington, Connecticut. Dr. Germain is rated as an Elite provider by MediFind in the treatment of Albright's Hereditary Osteodystrophy. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Albright's Hereditary Osteodystrophy, Pseudohypoparathyroidism, Acrodysostosis, and Dysostosis Peripheral.
Molecular Medicine And Neuroscience
Lee Weinstein is an Endocrinologist practicing medicine in Bethesda, Maryland. Dr. Weinstein is rated as an Elite provider by MediFind in the treatment of Albright's Hereditary Osteodystrophy. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Multiple Endocrine Neoplasia, Multiple Endocrine Neoplasia Type 1, Albright's Hereditary Osteodystrophy, Parathyroidectomy, and Thymectomy.
Background: Parathyroid disorders are very common in the general population and include disorders of parathyroid excess, deficiency, or defects in parathyroid hormone (PTH) signaling. PTH, the main secretory product of parathyroid glands is responsible for regulation of calcium-phosphate homeostasis.
Summary: The goal of this observational study is to describe the natural history of imprinting disorders (IDs) according to their metabolic profile in all patients (adults and children) affected with an ID regardless of the severity of the disease, with a molecular characterization, with a signed informed consent for all subjects, followed in one partner's center. The main questions it aims to answer are: ...